Annette Campbell-White was born and raised in New Zealand, but due to her father’s job as a mining engineer, she attended university in South Africa. She studied engineering, but not seeing a career path in the traditionally male-dominated spaces of engineering, Campbell-White decided to pursue chemical and medical engineering. She began working at Groote Schuur Hospital in Cape Town, where she focused on nuclear medicine. Due to apartheid, Campbell-White could not work with patients of different races at the same time. Growing frustrated with these restrictions, Campbell-White left South Africa to work for British Oxygen in 1973. There, she was tasked with researching medical ultrasounds, which took her to the United States. Wanting to return to the country to work, Campbell-White maintained contact with the company SRI. In 1975, she was offered a position as a health economist at SRI and moved to the United Stated. After building a rapport with her clients, Campbell-White left SRI to do independent contract work. She later joined Hambrecht & Quist after they contacted her about starting a health care group. Campbell-White had never worked in venture capital before but joined Hambrecht-Quist regardless. She made partner in 1981 and worked with biotech companies such as XOMA. Campbell-White left Hambrecht & Quist in 1983, briefly working for LF Rothschild before starting her own life sciences and medical devices venture capital firm, MedVenture, with the support of US Venture Partners and InterWest. While Campbell-White was successful in raising funds for her new firm, she took hiatuses due to cancer diagnoses. MedVenutre currently has fourteen companies in their portfolio, including Cutera. Outside of her work, Campbell-White is an avid collector of rare books, specializing in first editions.